Subject: It's Friday! Time to take the EASL Quiz
From: EASL Office <[email-masked]>
To: [email-masked]
Date: Fri, 03 Jul 2020 07:30:46 +0000

03 July 2020

Read online

EASL Quiz "Test your Guidelines Knowledge"

Ready to challenge your knowledge? Discover the third EASL Quiz

A 55-year-old man with cirrhosis due to alcoholic liver disease is admitted to the hospital with a large hematemesis. He has a history of ascites that has required prior hospital admissions. He has no history of hepatic encephalopathy or other comorbid conditions. Current medications are furosemide (40 mg daily) and spironolactone (100 mg daily).

The patient is alert and oriented. His blood pressure is 79/50 mm Hg, his heart rate is 118 bpm, and he has no fever. He has features of chronic liver disease including multiple spider naevi on the thorax and palmar erythema, but no asterixis. Heart and lung examination are normal. His abdomen is distended with non-tense ascites. The patient's score on the Model for End-Stage Liver Disease (MELD) is 22.

Discover which management option is the most acutely needed for this patient!

Take the quiz now

Missed the previous EASL quizzes? Take them now

See the Viral Hepatitis related quiz

See the Methabolic, Alcohol and Toxicity related quiz

Register with early fees for The Digital International Liver Congress™ 2020

Our carefully curated selection of original live and on-demand content will bring you a scientific programme with unprecedented global relevance, reach, and convenience. Whether you are in the Americas, Africa, Asia, Europe or Oceania, all the key presentations and much more will be just a click away.

Very special registration rates are now available for this unique 100% digital event and EASL members will receive further reductions.

Early fees end in 12 days so it is time to register now!

Call for nominations for two new members of the EASL Young Investigators task force

EASL is now calling for nominations for two new members for the Young Investigators task force. The term for these members is from September 2020 to April 2023.

The call  is open from July 1st to September 15th  2020. An updated CV and a letter of motivation for joining the task force should be submitted.

Apply now for the EASL Young Investigators task force

For the latest news on education and hepatology,

follow us on Twitter @EASLedu and @EASLnews

Forward to a friend or colleague

EASL’s mission is supported by an unrestricted education grant from

Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60

www.easl.eu

[email-masked]

Update your preferences or unsubscribe